Urokinase an enzyme protein isolated from the urine of a healthy person or
obtained from human kidney tissue culture. Can be direct effects on endogenous
fibrinolysis system, can into fibrinolytic enzyme catalytic cracking
fibrinolytic enzyme, which can not only degradation of fibrin clot, also can
degrade fibrinogen in blood, and clotting factor Ⅴ and blood coagulation factor
Ⅷ etc, so as to play a role of thrombolysis. Urokinase has a quick and good
effect on newly formed thrombosis, and can also improve the activity of vascular
ADP enzyme, inhibit adp-induced platelet aggregation, and prevent thrombosis.
After intravenous infusion, the fibrinolytic activity in the patient's body was
significantly increased, and the fibrinolytic activity returned to its original
level several hours after the drug was discontinued.
The prospect of urokinase application
At present, urokinase has been well applied in the medical field and is
widely used, and it is expected to develop more functions. It will get different
results with different drugs, and it is expected to contribute to the synthesis
of drugs. It has great potential value in the development of new drugs, and is
easy to obtain and has many sources.